Creative Biolabs has established a high-throughput AntInfect™ Platform for biomolecular development against infectives. Our scientists employ antigen-specific B lymphocytes cytometry technology, hybridoma technology and phage display technology for anti-bacteria antibody development. https://www.creative-biolabs.c....om/antinfect/anti-ba
Like
Comment
Share
